LJ Bonnett, A Shukralla, C Tudur-Smith… - Journal of Neurology, …, 2011 - jnnp.bmj.com Background In the UK, patients with epilepsy in remission, who withdraw antiepileptic drug (AED) treatment, are advised not to drive during withdrawal and for 6 months thereafter, assuming the risk of recurrence in the next 12 months is below 20%. Those with a seizure ... Related articles - All 3 versions
GE McKellar, R Hampson, A Tierney… - The Journal of …, 2011 - jrheum.org ... Rheumatoid Arthritis Nonsteroidal Antiinflammatory DrugWithdrawal in Patients with Stable 1. Sign up for our monthly e-table of contents http://www.jrheum.org/cgi/alerts/etoc ... Nonsteroidal Antiinflammatory DrugWithdrawal in Patients with Stable Rheumatoid Arthritis ... Related articles - All 3 versions
J Edge, S Gold - Current Pharmaceutical Design, 2011 - ingentaconnect.com Abstract: 'Globesity' is a descriptive term for the obesity epidemic now facing the US and indeed, the world. Hyperphagia (ie over- eating) can lead to metabolic syndrome which in turn can lead to Type 2 diabetes mellitus, heart disease, stroke and some cancers. The World ... Related articles - All 2 versions
KS Ziemba, KE Wellik, C Hoffman-Snyder… - The …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 2 versions
C Froger-Colléaux, S Rompion, P Guillaume… - … of Pharmacological and …, 2011 - Elsevier The results show that during the treatment phase chronic morphine reduced food intake and body weight gain, increased body temperature, HR, mean ABP and LMA. These effects continued over the 20 days of treatment. In contrast, chlordiazepoxide slightly increased food intake ... All 2 versions